Martina Squitieri

University of Florence

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Francesca Pescini

Azienda Ospedaliero-Universitaria Careggi

Anna Poggesi

University of Florence

Barbara Petolicchio

Sapienza University of Rome

Alessandro Viganò

Don Carlo Gnocchi Foundation

Massimiliano Toscano

Sapienza University of Rome

Emilia Salvadori

Don Carlo Gnocchi Foundation

Leonardo Pantoni

Luigi Sacco Hospital

Vittorio Di Piero

Sapienza University of Rome

E Gilliéron

University of Florence

Guido Chiti

Azienda Usl Toscana Centro

Cooperative Institutions

University of Florence

Azienda Ospedaliero-Universitaria Careggi

Don Carlo Gnocchi Foundation

Istituti di Ricovero e Cura a Carattere Scientifico

Sapienza University of Rome

University College London

National Hospital for Neurology and Neurosurgery

Vita-Salute San Raffaele University

Università Campus Bio-Medico

University of Milan

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Cerebral Cortex (2023)

Fabio Giovannelli Alessandra Borgheresi Giulia Lucidi Martina Squitieri Gioele Gavazzi

Abstract Linguistic tasks facilitate corticospinal excitability as revealed by increased motor evoked potential (MEP) induced by transcranial magnetic stimulation (TMS) in the dominant hand. This modulation of the primary motor cortex (M1) excitability may reflect the relationship between speech and gestures. It is conceivable that in healthy individuals who use a sign language this cortical excitability modulation could be rearranged. The aim of this study was to evaluate the effect of spoken language tasks on M1 excitability in a group of hearing signers. Ten hearing Italian Sign Language (LIS) signers and 16 non-signer healthy controls participated. Single-pulse TMS was applied to either M1 hand area at the baseline and during different tasks: (i) reading aloud, (ii) silent reading, (iii) oral movements, (iv) syllabic phonation and (v) looking at meaningless non-letter strings. Overall, M1 excitability during the linguistic and non-linguistic tasks was higher in LIS group compared to the control group. In LIS group, MEPs were significantly larger during reading aloud, silent reading and non-verbal oral movements, regardless the hemisphere. These results suggest that in hearing signers there is a different modulation of the functional connectivity between the speech-related brain network and the motor system.

Facilitation

10.1093/cercor/bhac536

Cite

Citations (0)

O049. Psychodynamic functioning in chronic headache patients: a short term psychodynamic psychotherapy (STPP) study

The Journal of Headache and Pain (2015)

Barbara Petolicchio Martina Squitieri Alessandro Viganò Massimiliano Toscano Arianna Sirolli

Background Chronic headache (CM) occurs in 2-5% of the general population, often associated with medication-overuse headache (MOH), and comorbid psychiatric disorders [1,2]. Among therapeutic approaches, psychotherapeutic interventions may be effective, either alone or associated with pharmacological therapies. As we previously showed, the short-term psychodynamic psychotherapy (STPP), plus drug therapy, is more effective in patients with probable MOH to reduce headache symptoms and relapse rate than drug therapy alone [3]. Moreover, STPP alone is not inferior to valproate in CM, as preventive therapy [4]. According to psychodinamic diagnosis (BPI) some psychodynamic profiles with poor ability to process the emotional content or low mentalizing level (i.e., pre-psychosis, psychosis and borderline) could be at risk of developing chronic headaches. The aim of the present study was to identify the most frequent psychodynamic profiles in CM and test the effective of STPP in those patients with no record of psychiatric disorders.

Psychodynamics

Pain medicine

Psychodynamic Psychotherapy

10.1186/1129-2377-16-s1-a105

Cite

Citations (5)

Corrigendum to: “A case of Takotsubo syndrome during a multiple sclerosis brainstem relapse” [Mult. Scler. Relat. Disord. 24 (2018) 1–2]

Multiple Sclerosis and Related Disorders (2019)

Elio Prestipino Martina Squitieri Lorenzo Razzolini Luisa Pastò Paolo Forleo

Cardiotoxicity

Takotsubo Syndrome

10.1016/j.msard.2019.03.010

Cite

Citations (4)

P053. An Italian study on the actual cost/benefit of onabotulinumtoxinA (BT-A) in chronic migraine: preliminary results

The Journal of Headache and Pain (2015)

Barbara Petolicchio Massimiliano Toscano Martina Squitieri Alessandro Viganò Edoardo Vicenzini

Background In Italy, the estimated cost of chronic migraine (CM) is around six billion euros per year (Agenas, 2011) considering the health costs, the loss in working productivity and quality of life. The efficacy of BT-A in the prophylactic treatment of CM has been demonstrated [1]. However, BT-A therapy is expensive and the limited health service resource may raise the question of the cost/benefit ratio. Ruggeri et al [1] carried out a study to provide an estimate of the incremental cost-effectiveness ratio of the treatment of CM with BT-A 2 . They compared the benefit as extrapolated from the PREEMPT data with those of a population of CM from the METEOR study, as well as with those of an actual population of CM from a district of Rome [1]. In the present study we compared actual costs and benefit in a CM population before and after BT-A treatment.

Chronic Migraine

Pain medicine

Migraine Disorders

10.1186/1129-2377-16-s1-a112

Cite

Citations (0)

Author Correction: Cognitive profile in cerebral small vessel disease: comparison between cerebral amyloid angiopathy and hypertension-related microangiopathy

Scientific Reports (2024)

Eleonora Barucci Emilia Salvadori Simona Magi Martina Squitieri G. Fiore

Microangiopathy

Angiopathy

Amyloid (mycology)

10.1038/s41598-024-59216-y

Cite

Citations (0)

Cognitive and imaging correlates in cerebral amyloid angiopathy subtypes

Journal of the Neurological Sciences (2019)

Guendalina Bonifacio Edgar Chan Martina Squitieri Shofiqul Islam David J. Werring

Cognitive Decline

Pittsburgh compound B

10.1016/j.jns.2019.10.746

Cite

Citations (0)

CEREBRAL AIR EMBOLISM: A NON-THROMBOTIC CAUSE OF STROKE

Martina Squitieri

Stroke

Cerebral embolism

Intracranial Embolism

10.26226/morressier.5ab8f55ad462b8029238d41e

Cite

Citations (0)

Cognitive profile in cerebral small vessel disease: comparison between cerebral amyloid angiopathy and hypertension-related microangiopathy

Scientific Reports (2024)

Eleonora Barucci Emilia Salvadori Simona Magi Martina Squitieri G. Fiore

Abstract Cerebral amyloid angiopathy (CAA) is recognized as a cause of cognitive impairment, but its cognitive profile needs to be characterized, also respect to hypertension-related microangiopathy (HA). We aimed at comparing difference or similarity of CAA and HA patients’ cognitive profiles, and their associated factors. Participants underwent an extensive clinical, neuropsychological, and neuroimaging protocol. HA patients (n = 39) were more frequently males, with history of vascular risk factors than CAA (n = 32). Compared to HA, CAA patients presented worse performance at MoCA (p = 0.001) and semantic fluency (p = 0.043), and a higher prevalence of amnestic MCI (46% vs. 68%). In univariate analyses, multi-domain MCI was associated with worse performance at MoCA, Rey Auditory Verbal Learning Test (RAVLT), and semantic fluency in CAA patients, and with worse performance at Symbol Digit Modalities Test (SDMT) and phonemic fluency in HA ones. In multivariate models, multi-domain deficit remained as the only factor associated with RAVLT (β = − 0.574) in CAA, while with SDMT (β = − 0.364) and phonemic fluency (β = − 0.351) in HA. Our results highlight different patterns of cognitive deficits in CAA or HA patients. While HA patients’ cognitive profile was confirmed as mainly attentional/executive, a complex cognitive profile, characterized also by deficit in semantic memory, seems the hallmark of CAA patients.

Microangiopathy

Verbal fluency test

Montreal Cognitive Assessment

Cognitive Decline

10.1038/s41598-024-55719-w

Cite

Citations (2)

Efficacy and Safety of the Association of Nimodipine and Choline Alphoscerate in the Treatment of Cognitive Impairment in Patients with Cerebral Small Vessel Disease. The CONIVaD Trial

Drugs & Aging (2021)

Emilia Salvadori Anna Poggesi Ida Donnini Valentina Rinnoci Guido Chiti

No approved treatment is available for patients with vascular cognitive impairment (VCI) due to cerebral small vessel disease (SVD).

Nimodipine

Pharmacotherapy

10.1007/s40266-021-00852-8

Cite

Citations (12)

Cerebral venous thrombosis: a practical guide

Practical Neurology (2020)

Leonardo Ulivi Martina Squitieri Hannah Cohen Peter Cowley David J. Werring

All neurologists need to be able to recognise and treat cerebral venous thrombosis (CVT). It is difficult to diagnose, partly due to its relative rarity, its multiple and various clinical manifestations (different from ‘conventional’ stroke, and often mimicking other acute neurological conditions), and because it is often challenging to obtain and interpret optimal and timely brain imaging. Although CVT can result in death or permanent disability, it generally has a favourable prognosis if diagnosed and treated early. Neurologists involved in stroke care therefore also need to be aware of the treatments for CVT (with varying degrees of supporting evidence): the mainstay is prompt anticoagulation but patients who deteriorate despite treatment can be considered for endovascular procedures (endovascular thrombolysis or thrombectomy) or neurosurgery (decompressive craniotomy). This review summarises current knowledge on the risk factors, diagnosis, treatment and prognosis of CVT in adults, and highlights some areas for future research.

Stroke

Decompressive craniectomy

10.1136/practneurol-2019-002415

Cite

Citations (165)